Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Clinical Study to Evaluate the Safety and Performance of the Gastric Bypass Stent System as a Weight Loss Treatment for Obesity

NCT05938231 is registered in ClinicalTrials.gov with Hangzhou Tangji Medical Technology Co., Ltd. as lead sponsor.

NCT NCT05938231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05938231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Clinical Study to Evaluate the Safety and Performance of the Gastric Bypass Stent System as a Weight Loss Treatment for Obesity
Lead sponsor
Hangzhou Tangji Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2021
Completion date
October 7, 2022
Enrollment
99 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

obesity